DMT

Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief
Beyond The Brain: Heart Activity May Shape Psychedelic Experiences, Study Finds
Pro Golfers Turn To Psychedelics For Focus Boost And Anxiety Relief
Beyond The Brain: Heart Activity May Shape Psychedelic Experiences, Study Finds
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials

DMT Recent News

Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
SciSparc & Clearmind file patents for LSD, psilocybin, DMT blends, advancing psychedelic therapeutics for mental health.
DEA Raises THC, Psilocybin And DMT Production Quotas For Scientific Research Purposes
The Drug Enforcement Administration (DEA) is proposing the production of higher amounts of THC, psilocybin and DMR for research in 2024.
More Protocols And Guidance Are Needed As Momentum Builds For Veterans, Psychedelics, And Mental Health
Studies and reports from the U.S. Department of Veterans Affairs (VA) and other research publications suggest that an estimated 20-30% of U.S.
Psychedelics In Mexico: Are They Legal? Well, Yes And No
This article was originally published on Psychedelic Spotlight and appears here with permission. For the most part, psychedelics are still illegal in Mexico with a few exceptions.
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
Small Pharma Inc. (OTCQB: DMTTF), the short-acting psychedelics biotech about to be purchased by Cybin Inc.
The Fear Of Death Dissolved: How Psychedelic Trips And Near-Death Moments Change Our Outlook On Life's End
This article was originally published on Psychedelic Spotlight and appears here with permission.
How DMT Affects The Brain's Advanced Functions, Scientists Reveal The Truth
This article was originally published on Psychedelic Spotlight and appears here with permission. Scientists reveal new insights into how DMT affects various regions of the brain.
Study Sheds Light On How A Brain On Ayahuasca's Psychedelic Component Looks
A new study reveals the most advanced-to-date brain images of the effects of the psychedelic compound DMT.
DMT VS. Psilocybin: Are We All Experiencing The Same Trip?
This article was originally published on Psychedelic Spotlight and appears here with permission. DMT and psilocybin are both powerful elements of Mother Nature's alchemy, but do they offer an identical journey? Let’s explore to find out.
Cybin Approved For First In-Human Dosing Of DMT Molecule CYB004, Milestone For Anxiety Disorder Treatment
Cybin Inc. (NYSE: CYBN) announced that it has received approval from an independent ethics committee in the Netherlands to begin the first in-human dosing of its proprietary deuterated N, N-dimethyltryptamine (DMT) molecule CYB004 through a protocol amendment to its ongoing CYB004-E Phase 1 trial. 
Top 3 Psychedelic Storylines To Watch In 2023
This article by James Hallifax was originally published on Microdose and appears here with permission.
EXCLUSIVE: Defining 'Natural' Psychedelics, State Regulations & Ayahuasca's Benefits
(Part three of a three-part series) See previous stories: EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
Canadian clinical-stage psychedelics company Algernon Pharmaceuticals (OTCQB: AGNPF)’s newly created subsidiary Algernon NeuroScience (AGN Neuro) has dosed
Ayahuasca's Benefits Outweigh Risks, A New Australian Study Finds
In Australia, a new study conducted by the University of Melbourne analyzed data from an Online Global Ayahuasca Survey conducted between 2017 and 2019 that showed 10,836 people over the age of 18 had
This Novel Short-Acting Psychedelic Compound Is Ready For First Phase 1 Clinical Try-Out
Small Pharma Inc.
A Foundational Study On Stroke Is Ready. Here Is Why It's Important
Biopharma company Algernon Pharmaceuticals Inc's (OTC: AGNPF) recently announced plan for a Phase 1 clinical study on DMT for huma
DMT Producer PsyBio And Shrooms Grower Red Light Holland Share Their Most Recent Financial Results
PsyBio Therapeutics (TSXV: PSYB) (OTCQB: PSYBF), a biotech developing medicines based on naturally-occurring psychedelic substances, and mushroom producer Red Light Holland Corp. (OTC Pink: TRUFF) announced the
Science Feature: Next-Generation Psychedelics
This article was originally published on Microdose and appears here with permission.
Is Smoking DMT Safe?
This article was originally published on Psychedelic Spotlight and appears here with permission. DMT is a popular hallucinogen being studied for its therapeutic potential, but is smoking DMT safe? Here’s everything you need to know.
Encountering DMT Entities: Are They Real?
This article was originally published on Psychedelic Spotlight and appears here with permission. DMT is a powerful hallucinogen famous for producing experiences of encounters with entities, but how many people actually see them?
A Deeper Look At DMT Trials & Studies
This article by Elisabetta Fato was originally published on Microdose and appears here with permission.
EXCLUSIVE: How Cybin Is Developing The Next Generation Of Psychedelics
If you’re just now considering the therapeutic value of psychedelics, Cybin Inc (NYSE: CYBN) is many trips ahead of you.
Extending the Experience: Interview With DMT Pioneer Rick Strassman

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved